Dr. Coleman on the Future of PARP Inhibitors in Ovarian Cancer
September 29th 2018
Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses the future of PARP inhibitors in patients with ovarian cancer.